We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use °Ç¸ç³Ô¹Ï, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Outcome(s) by the Central Arbitration Committee on an application from the RMT.
Statement by the Foreign Secretary, David Lammy, at the UN General Assembly High-Level Meeting on antimicrobial resistance
First published during the 2024 to 2026 Starmer Labour government
New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.
Patients taking Crescent Pharma Limited Ramipril 2.5mg capsules are advised to check their packaging for batch number GR155023 and contact their pharmacy if any blister strips inside are labelled as Ramipril 10mg.
The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in the UK’s thriving £100 billion life sciences industry.
The Competition and Markets Authority (CMA) is investigating the completed acquisition by Aramark Limited of Entier Limited.
Proposed Rare Disease Therapies Framework introduces Investigational Marketing Authorisation and compressed development pathways – industry urged to respond
Summary of the latest safety advice for medicines and medical device users
Amiodarone has been associated with serious and potentially life-threatening side effects, particularly of the lung, liver, and thyroid gland. We remind healthcare professionals that patients should be supervised and reviewed regularly during treatment. Lung problems may have slow onset but...
The MHRA launches public consultation on new framework that could lead to earlier licensing for therapies for up to 3.5 million people in the UK.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve °Ç¸ç³Ô¹Ï, we’d like to know more about your visit today. .